```html

Yellow Discoloration of the Eyes (Scleral Icterus)

What is Yellow discoloration of the eyes (scleral icterus)?

Scleral icterus, commonly described as a yellowing of the whites of the eyes (the sclera), is a visible sign that the blood contains an excess of bilirubin—a yellow pigment that is produced when the body breaks down old red blood cells. When bilirubin levels rise faster than the liver can process and eliminate it, the pigment accumulates in tissues, most noticeably in the skin and sclera. The eye sclera is thin and highly vascular, making it a sensitive early indicator of elevated bilirubin (hyperbilirubinemia).

While many people associate a “yellow tint” with jaundice, scleral icterus can appear before the skin color changes, giving clinicians an early clue that something is affecting the liver, bile ducts, or red‑blood‑cell turnover.

Common Causes

Below are the most frequent medical conditions that lead to scleral icterus. Some are acute and reversible; others signal chronic disease.

• Hepatitis (viral, alcoholic, or drug‑induced) – Inflammation impairs bilirubin processing.
• Gallstones or Biliary Obstruction – Blocked bile flow causes bilirubin to back‑up into the bloodstream.
• Hemolytic Anemia – Accelerated red‑cell destruction releases large amounts of bilirubin.
• Non‑alcoholic Fatty Liver Disease (NAFLD) / Non‑alcoholic Steatohepatitis (NASH) – Common in obesity and metabolic syndrome.
• Alcoholic Liver Disease – Chronic alcohol use damages hepatocytes.
• Primary Biliary Cholangitis & Primary Sclerosing Cholangitis – Autoimmune diseases that scar the bile ducts.
• Medication‑Induced Liver Injury – Examples include acetaminophen overdose, certain antibiotics, and antiretrovirals.
• Gilbert’s Syndrome – A benign, inherited reduction in bilirubin‑conjugating enzyme activity; often unmasked by fasting or illness.
• Pancreatic Cancer (head of pancreas) – Can compress the common bile duct.
• Sepsis or severe infections – May cause transient liver dysfunction and cholestasis.

Associated Symptoms

Scleral icterus rarely occurs in isolation. Look for these accompanying signs that may help pinpoint the underlying cause:

• Dark urine (bilirubin excreted in urine)
• Pale or clay‑colored stools (lack of bilirubin in the intestines)
• Generalized skin yellowing (jaundice)
• Upper right abdominal pain or tenderness
• Pruritus (itchy skin), especially on palms and soles
• Fatigue, weakness, or unexplained weight loss
• Fever or chills (suggesting infection)
• Abdominal fullness, bloating, or vomiting (possible obstruction)
• Joint pain or rash (may point toward autoimmune liver disease)
• Bruising or bleeding easily (indicating impaired clotting factors)

When to See a Doctor

Because scleral icterus signals a disturbance in bilirubin metabolism, prompt evaluation is crucial. Seek medical attention if you notice any of the following:

• Yellowing of the eyes that persists for more than 24–48 hours.
• Concurrent dark urine, pale stools, or itchy skin.
• Severe abdominal pain, especially in the upper right quadrant.
• Fever, chills, or rapid worsening of symptoms.
• Unexplained weight loss, loss of appetite, or persistent nausea/vomiting.
• Bleeding gums, easy bruising, or blood in the stool.
• History of recent medication change, excessive alcohol intake, or known liver disease.

Diagnosis

Healthcare providers combine a physical exam with targeted tests to determine why bilirubin is elevated.

1. History & Physical Examination

• Detailed medication, alcohol, and family‑history review.
• Assessment of abdominal tenderness, liver size, and presence of ascites.
• Inspection of skin and sclera for the degree of yellowing.

2. Laboratory Tests

• Serum Bilirubin – Total and direct (conjugated) levels differentiate hepatocellular from obstructive causes.
• Liver Enzyme Panel – ALT, AST, ALP, GGT help locate the problem (hepatocellular vs cholestatic).
• Complete Blood Count (CBC) – Detects hemolysis, infection, or anemia.
• Coagulation Studies (PT/INR) – Liver synthetic function.
• Viral Hepatitis Serologies – Hepatitis A, B, C, and sometimes E.
• Autoimmune Markers – ANA, SMA, AMA for autoimmune liver disease.

3. Imaging Studies

• Ultrasound – First‑line to assess liver texture, gallbladder, and ducts.
• CT or MRI – Detailed view for masses, strictures, or pancreatic lesions.
• MRCP (Magnetic Resonance Cholangiopancreatography) – Non‑invasive ductal imaging.

4. Specialized Tests (when indicated)

• Liver Biopsy – Provides definitive histology for chronic liver disease.
• Hemolysis Work‑up – Haptoglobin, LDH, reticulocyte count, peripheral smear.
• Genetic Testing – For Gilbert’s syndrome or other hereditary bilirubin disorders.

Treatment Options

Treatment focuses on the underlying cause; the yellow eye color usually resolves once bilirubin levels normalize.

1. Addressing Liver Disease

• Viral Hepatitis – Antiviral therapy (e.g., sofosbuvir/velpatasvir for HCV, tenofovir for HBV).
• Alcohol‑Related Liver Injury – Complete abstinence, nutritional support, and possibly corticosteroids for alcoholic hepatitis.
• NAFLD/NASH – Weight loss (7–10 % of body weight), exercise, and management of diabetes/hyperlipidemia.
• Autoimmune Cholestatic Diseases – Ursodeoxycholic acid (UDCA) for primary biliary cholangitis; immunosuppressants for primary sclerosing cholangitis.

2. Treating Biliary Obstruction

• Endoscopic Retrograde Cholangiopancreatography (ERCP) to remove stones or place stents.
• Surgical cholecystectomy or bile‑duct reconstruction for recurrent obstruction.
• Radiologic drainage (percutaneous) if endoscopic access is not possible.

3. Managing Hemolysis

• Stop offending drugs (e.g., certain antibiotics, antimalarials).
• Treat underlying autoimmune hemolytic anemia with steroids or rituximab.
• Blood transfusion in severe anemia.

4. Symptomatic & Supportive Care

• Hydration to support kidney clearance of bilirubin.
• Pruritus relief with cholestyramine, antihistamines, or rifampin.
• Vitamin K supplementation if clotting factors are low.

5. Home‑Based Measures (Adjunctive)

• Maintain a balanced diet low in saturated fat and high in fiber.
• Avoid alcohol and hepatotoxic over‑the‑counter supplements (e.g., high‑dose “herbal” products).
• Stay up‑to‑date with vaccinations for hepatitis A and B.

Prevention Tips

While not all causes are preventable, many risk factors can be modified:

• Limit Alcohol Intake – No more than 1 drink per day for women, 2 for men.
• Vaccinate against hepatitis A and B.
• Practice Safe Sex and avoid sharing needles to reduce viral hepatitis risk.
• Maintain Healthy Weight – Aim for BMI 18.5–24.9 to lower NAFLD risk.
• Use Medications Wisely – Follow dosing instructions; discuss liver‑friendly alternatives with your doctor.
• Regular Check‑ups – Annual liver function tests for high‑risk individuals (e.g., chronic alcohol users, diabetics).
• Promptly Treat Infections – Particularly cholangitis or gallbladder disease.

Emergency Warning Signs

References

• Mayo Clinic. “Jaundice.” https://www.mayoclinic.org
• American Liver Foundation. “Understanding Liver Tests.” https://liverfoundation.org
• CDC. “Hepatitis A, B, and C.” https://www.cdc.gov
• NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Nonalcoholic Fatty Liver Disease.” https://www.niddk.nih.gov
• Cleveland Clinic. “Biliary Obstruction.” https://my.clevelandclinic.org
• World Health Organization. “Guide to Hepatitis.” https://www.who.int

```